Dr. Mehmet Oz, administrator for the Centers for Medicare & Medicaid Services, discusses the Trump administration’s efforts ...

A five-year experiment aims to open access to blockbuster GLP‑1 drugs for obesity, something advocates have pushed for years.

Medicare and Medicaid could expand coverage of GLP-1 drugs, such as Ozempic and Wegovy, and pay for patients’ use of the ...

Blockbuster weight loss drugs like Wegovy and Zepbound have surged in popularity, but high prices have left them out of reach ...

Leadership at the Centers for Medicare and Medicaid Services is working with states to develop plans to use the $50 billion ...

When it comes to attracting mega-donors, Republicans are crushing Democrats. By Theodore Schleifer There are many signs that ...

President Donald Trump set a deadline of Sept. 19 for pharmaceutical companies to commit to complying with his demands of ...

Proposed experiment would allow states and Medicare drug plans to cover GLP-1 drugs like Ozempic and Wegovy for obesity, The ...

Apple, Google, and OpenAI join CMS in a major push to unify health records, boost AI tools, and improve patient access across ...

The Trump administration is planning an experiment to cover weight loss drugs under Medicare and Medicaid, potentially ...

Led by CMS Administrator Dr. Mehmet Oz, the National Health Tech project fosters a voluntary, standards-based ecosystem where electronic health records (EHRs), mobile apps, and connected tools ...